Bezlotoxumab Efficacy and Tolerability in Cancer Patient

Clinical trial NCT04415918 · UNKNOWN

Trial details

NCT number: NCT04415918
Sponsor: The Cooper Health System
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Clostridium Difficile Infection Recurrence

Start date: 2020-07-01
Primary completion: 2021-07-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.